scispace - formally typeset
E

Edward D. Plowey

Researcher at Stanford University

Publications -  29
Citations -  6807

Edward D. Plowey is an academic researcher from Stanford University. The author has contributed to research in topics: Autophagy & Neurodegeneration. The author has an hindex of 13, co-authored 27 publications receiving 6056 citations. Previous affiliations of Edward D. Plowey include University of Pittsburgh.

Papers
More filters
Journal ArticleDOI

Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)

Daniel J. Klionsky, +2522 more
- 21 Jan 2016 - 
TL;DR: In this paper, the authors present a set of guidelines for the selection and interpretation of methods for use by investigators who aim to examine macro-autophagy and related processes, as well as for reviewers who need to provide realistic and reasonable critiques of papers that are focused on these processes.
Journal ArticleDOI

Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SH-SY5Y cells.

TL;DR: Results indicate an active role for autophagy in neurite remodeling induced by pathogenic mutation of LRRK2, implicating MAPK/ERK‐related signaling.
Journal ArticleDOI

A combination of ontogeny and CNS environment establishes microglial identity.

TL;DR: A brain macrophage transplantation system is created to disentangle how environment and ontogeny specify microglial identity, and it is found that donor cells extensively engraft in the CNS of microglia-deficient mice, and even after exposure to a cell culture environment,microglia fully regain their identity when returned to the CNS.
Book ChapterDOI

Autophagy in neurite injury and neurodegeneration: in vitro and in vivo models

TL;DR: Several molecular cell biological and imaging methods to study autophagy and mitophagy in neuritic and somatic compartments of differentiated neuronal cell lines and primary neuron cultures are highlighted, using protocols developed in toxic and genetic models of parkinsonian neurodegeneration.
Journal ArticleDOI

First-in-human intraoperative near-infrared fluorescence imaging of glioblastoma using cetuximab-IRDye800

TL;DR: This first-in-human study demonstrates the feasibility and safety of antibody based imaging for CE glioblastomas by determining if therapeutic antibodies could be repurposed for intraoperative imaging during resection.